Fantastic. Made up, unaudited bs from a company with no integrity and even less credibility.
Schills can try to paint this like it's a good thing but the move to AR only allows for a less transparent means for pink sheet companies to defraud investors. The otc puts the onous on company executives to be forthcoming. To be clear, there is no assurance offered by otc to the accuracy of reports.
There is a reason most public companies use sec fillings as otc ar fillings are only as reliable as the companies filling them, which in this case, isn't very reliable.
Good luck if you're relying on pct to be forthcoming.